SCHEMBL6558726

SCHEMBL6558726

[O][N]CCCNS(=O)(=O)c1ccc(Oc2cccnc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TBXAS1 P24557 6/20 0.49
▸ MMP2 P08253 6/20 0.46
▸ CA12 O43570 5/20 0.46
▸ CA1 P00915 5/20 0.46
▸ CA2 P00918 5/20 0.46
▸ CA9 Q16790 5/20 0.46
▸ FFAR4 Q5NUL3 1/20 0.46
▸ MMP13 P45452 2/20 0.44
▸ MMP1 P03956 2/20 0.44
▸ ADAMTS4 O75173 1/20 0.44
▸ MMP14 P50281 1/20 0.44
▸ ADAMTS5 Q9UNA0 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ PKM P14618 1/20 0.44
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6558721 0.91 TBXAS1 (0.49) TBXAS1MMP2CA12CA1CA2
SCHEMBL6557786 0.72 ALDH1A1 (0.48) TBXAS1MMP2FFAR4MMP13MMP1
SCHEMBL2845658 0.72 LMNA (0.55) CA12CA1CA2CA9FFAR4
SCHEMBL6557790 0.71 MMP1 (0.50) TBXAS1MMP2FFAR4MMP13MMP1
SCHEMBL6558732 0.70 MMP1 (0.50) TBXAS1MMP2FFAR4MMP13MMP1
SCHEMBL5445643 0.70 ALDH1A1 (0.51) TBXAS1MMP2FFAR4MMP13MMP1
SCHEMBL5445650 0.70 ALDH1A1 (0.48) TBXAS1MMP2CA2CA9FFAR4
SCHEMBL16114401 0.69 LMNA (0.75) ALDH1A1CYP1A2CYP3A4HTTSMN1; SMN2
SCHEMBL10029061 0.69 MMP2 (0.63) MMP2CA12CA1CA2CA9
SCHEMBL4521900 0.69 ALDH1A1 (0.74) MMP2CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 — — EP disclosed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 — — WO disclosed
Send feedback